80 results
Page 2 of 4
8-K
EX-10.1
uge6rzrlrgfkt9
27 Oct 14
CTI Acquires Exclusive Worldwide License to Tosedostat, a Selective Oral Anti-Cancer Therapy
12:00am
8-K
EX-10.2
xc1u6u6irgntwq
27 Oct 14
CTI Acquires Exclusive Worldwide License to Tosedostat, a Selective Oral Anti-Cancer Therapy
12:00am
8-K
EX-10.1
mnu0ag 16y4fcirgjc7
4 Sep 12
Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
12:00am
8-K
EX-10.1
zz2i1pn1tyrtztx
24 Apr 12
Cell Therapeutics Enters into Agreement to
12:00am
8-K
EX-10.1
s7bgt5x1 os
15 Nov 11
Cell Therapeutics, Inc. Reports Results of
12:00am
8-K
EX-10.1
ecehwhu21oq9i3
17 Sep 10
Cell Therapeutics, Inc. Reports Outcome of
12:00am
8-K
EX-99.1
6o4nwp 3z5u15v
24 Aug 10
Other Events
12:00am